Abstract
Because use of sugar-containing paediatric medicines is an aetiological factor in dental caries, sugar-free alternatives are slowly becoming more readily available. However, it is claimed that, for a variety of reasons, their production is difficult. This investigation was undertaken to determine whether problems exist in the formulation, production and availability of sugar-free medicines. A structured questionnaire was used with personnel involved in the production, marketing and wholesaling of paediatric medicines in the UK. Information was obtained from interviews with, or from questionnaires completed by, personnel of five pharmaceutical and five wholesale companies. The findings indicated that the only obstacle to producing sugar-free medicines is slightly higher cost, and that manufacturers are influenced to change mainly by consumer pressure. It was concluded that the dental profession should advise the public to demand sugar-free medicines and doctors to prescribe them.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
